Foghorn Therapeutics (FHTX) Earnings Date & Reports
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
FHTX is expected to report earnings to fall 16.52% to -19 cents per share on May 12
Q1'25
Est.
$-0.19
Q4'24
Beat
by $0.12
Q3'24
Beat
by $0.12
Q2'24
Beat
by $0.19
Q1'24
Beat
by $0.03
The last earnings report on March 06 showed earnings per share of -23 cents, beating the estimate of -34 cents. With 224.24K shares outstanding, the current market capitalization sits at 177.18M.